Mayo Clinic scientists pioneer immunotherapy technique for autoimmune diseases

Mesenchymal stromal cell ROCHESTER, Minn. — Mayo Clinic scientists have developed an immunotherapy strategy that potentially lays the groundwork for treating a spectrum of autoimmune diseases. The new technique, detailed in a preclinical study published in Nature Biomedical Engineering, involves combining chimeric antigen receptors (CAR) with mesenchymal stromal cells (MSC),…

Continue reading

Mayo Clinic Platform expands global footprint of its distributed data network  

The first-of-its-kind alliance moves into new regions to transform global healthcare and improve access, diagnostics and treatments for patients everywhere. ROCHESTER, Minn. — Mayo Clinic Platform continues to expand its distributed data network, Mayo Clinic Platform_Connect1, which now includes eight of the world’s leading health systems across three continents: Seoul…

Continue reading

New study finds triple-negative breast cancer tumors with an increase in immune cells have lower risk of recurrence after surgery

ROCHESTER, Minn. — A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates even when not treated with chemotherapy. The study was published today in…

Continue reading

What’s the best nonhormonal therapy for hot flashes? Experts release new menopause therapy guidelines

New guidelines around the use of nonhormonal therapy for hot flashes — or vasomotor symptoms— due to menopause have been released by the North American Menopause Society. Dr. Juliana Kling, a women’s health specialist at Mayo Clinic and one of the authors of the new guidelines, says, “The new guidelines include a…

Continue reading